학술논문

M3258 is a selective inhibitor of the immunoproteasome subunit LMP7 (b5i) delivering efficacy in multiple myeloma models
Document Type
Article
Source
In: Molecular Cancer Therapeutics. (Molecular Cancer Therapeutics, August 2021, 20(8):1378-1388)
Subject
Language
English
ISSN
15388514
15357163